Skip to content

Industry-leading iPSC Gene Editing Technology

Get the highest precision and efficiency with Ncardia’s proprietary STAR-CRISPR technology

STAR-CRISPR far surpasses other established gene editing methodologies. 
Partner with Ncardia to: 
- Reduce unintended edits in oncogenes and coding regions
- Mitigate safety risks in iPSC genetic modifications
- Access knock-out efficiency of ~90%, surpassing Cas9 and MAD7
- Utilize knock-in efficiency up to 50%, 2-3 times higher than other methods

Power Your Research With STAR-CRISPR Technology

What to Expect From Ncardia iPSC Gene Editing Service

dd-Figure-1-2

Unmatched Efficiency

and minimal off-targets 

Streamlined Experience

With Ncardia's proprietary technology

Quick Turnaround

Get your iPSC line edited in 12-16 weeks

How Does STAR-CRISPR Measure Up?

CRISPR-based systems have two key components:
- Guide RNA (gRNA) — a short RNA sequence matching the target DNA sequence to be edited
- DNA cutting enzyme — typically Cas9 or their derivatives

Among all the CRISPR-based systems available to edit iPSCs, STAR-CRISPR stands out with:

 

Unparalleled efficiencies in gene knock-in and knock-out

 

Minimal off-target editing

Explore Related Services

 

Partner With the Proven iPSC Technology Experts

Are you ready to confidently advance your therapeutic candidates?

Start a Conversation